Previously, we were able to demonstrate improved kidney function in MMF-treated COL4A3−/− mice although the overall survival was not improved [22] and we therefore suggested that, in contrast to the other drugs studied, MMF might have an inhibitory effect on the initial tubulointerstitial fibrosis but not on glomerulosclerosis. This evidence concerns the gene COL4A3 and glomerulosclerosis.